Pre-Exposure Prophylaxis for HIV Prevention in Women: Current Status and Future Directions

@article{HodgesMameletzis2019PreExposurePF,
  title={Pre-Exposure Prophylaxis for HIV Prevention in Women: Current Status and Future Directions},
  author={I. Hodges-Mameletzis and V. Fonner and S. Dalal and N. Mugo and Busi Msimanga-Radebe and R. Baggaley},
  journal={Drugs},
  year={2019},
  volume={79},
  pages={1263 - 1276}
}
Pre-exposure prophylaxis (PrEP) is a promising intervention to prevent HIV acquisition, with benefits both to the individual and to population-level health. PrEP is an opportunity to complement ongoing public health efforts to eliminate HIV. For women, PrEP can also serve as a gateway to access sexual and reproductive health (SRH) services. Clinical efficacy of PrEP was initially reported in women using a 1% tenofovir vaginal gel in 2010, followed by an efficacy trial of oral PrEP using TDF/FTC… Expand
Pre-Exposure Prophylaxis for HIV Infection and the Role of the Women's Health Care Provider in HIV Prevention.
TLDR
Pre-exposure prophylaxis (PrEP) is an effective and safe HIV prevention method recommended for women at increased risk for HIV infection, including during pregnancy and lactation. Expand
Early pre-exposure prophylaxis (PrEP) discontinuation among pregnant and postpartum women: Implications for maternal PrEP roll out in South Africa
TLDR
Being postpartum and experiencing side effects were associated with lower PrEP continuation, presenting an opportunity for improved clinical management and counseling during pregnancy of nausea/vomiting to address early, transient side effects. Expand
Family planning providers' role in offering PrEP to women.
TLDR
By incorporating PrEP services into family planning care, family planning providers have the opportunity to meet women's expectations, ensure women are aware of and offered comprehensive HIV prevention options, and reverse emerging disparities in PrEP access. Expand
Effects Of HIV Oral Pre-Exposure Prophylaxis On Incidence Of STIS Among Female Sex Workers In Selected Drop-In Centers In Nairobi County.
TLDR
There was a notable increasing trend of STIs among FSWs using HIV PrEP; 0%, 7%, 13%, 16%, and 21%, from enrolment to month five, with the most notable STIs being vaginitis, cervicitis and Pelvic Inflammatory Disease (PID). Expand
Achievements and gaps to provide pre-exposure prophylaxis (PrEP) for women across the European Region – Results from a European survey study
TLDR
Women’s access to PrEP in Europe remains limited and women are often not included in the guidelines or targeted with education or information, resulting in a general lack of information about the use of PrEP for women. Expand
Integration of HIV Prevention With Sexual and Reproductive Health Services: Evidence for Contraceptive Options and HIV Outcomes Study Experience of Integrating Oral Pre-exposure HIV Prophylaxis in Family Planning Services in Lusaka, Zambia
The WHO guideline on the integration of family planning (FP) and pre-exposure HIV prophylaxis (PrEP) to enhance the health of women and adolescent girls is reflected in the Zambia ConsolidatedExpand
Uptake of Contraception Among Adolescent Girls and Young Women PrEP Clients: Leveraging the Opportunity to Strengthen HIV and Sexual and Reproductive Health Integration
The introduction of oral pre-exposure prophylaxis (PrEP) for HIV prevention was a major breakthrough in South Africa (SA). While the initial introduction focused on issues such as the development andExpand
Considerations for the Design of Pre-exposure Prophylaxis (PrEP) Interventions for Women: Lessons Learned from the Implementation of a Novel PrEP Intervention
TLDR
It is recommended that future interventions consider packaging PrEP in local community settings; include services such as food and housing assistance; use peers to recruit and educate women; integrate a culturally appropriate women’s focus; and consider providing same-day PrEP. Expand
Knowledge and barriers of PrEP delivery among diverse groups of potential PrEP users in Central Uganda
TLDR
Initial awareness of PrEP was low, but PrEP knowledge and interest increased among diverse MARPs after HCW training, and support to overcome barriers to PrEP use should be encouraged. Expand
HIV Pathogenesis in the Human Female Reproductive Tract
TLDR
Understanding how HIV establishes infection in the FRT can provide clues to develop novel interventions to prevent HIV acquisition in women, and a complex network of interrelated biological and sociocultural factors contributes to HIV risk in women and impairs prevention and cure strategies. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 123 REFERENCES
Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa.
TLDR
The need to continue to refine estimates of efficacy and effectiveness of tenofovir-based oral PrEP so as to best develop the next generation of HIV prevention tools, and to inform public policies directed toward HIV prevention is emphasized. Expand
A Review of HIV Pre-Exposure Prophylaxis: The Female Perspective
TLDR
The clinical evidence behind PrEP in women, current barriers to use afflicting this population, pharmacotherapy considerations for the female patient, alternative and future agents, and the current real-world application of PrEP are discussed. Expand
Preexposure Prophylaxis (PrEP) for HIV Prevention: The Primary Care Perspective
TLDR
PrEP is gaining widespread acceptance and has become a crucial tool in the fight to stop the spread of HIV, and this intervention is likely reaching only a small fraction of eligible patients. Expand
Pre-exposure prophylaxis prescribing and retention in care among heterosexual women at a community-based comprehensive sexual health clinic
TLDR
It is necessary to expand PrEP to women whose risk factors extend beyond being in a known sero-discordant partnership, and to understand the reasons for the observed drop-off in PrEP care visits in real-world settings. Expand
Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States
TLDR
A PrEP demonstration project that evaluated the safety, tolerability, and acceptability of TDF/FTC and patterns of use, rates of adherence, and pattern of sexual risk behavior among healthy young MSM aged 15 to 17 years found youth may need additional contact with clinical staff members to maintain high adherence. Expand
Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial.
TLDR
Differences in pregnancy incidence, birth outcomes, and infant growth were not statistically different for women receiving PrEP with TDF alone or combination FTC+TDF compared with placebo at conception, and definitive statements about the safety of PrEP in the periconception period cannot be made. Expand
Pre-exposure Prophylaxis for HIV Prevention
TLDR
This book provides an extensive description of PrEP from basic information to scientific studies and offers a concise and comprehensive description of how Truvada ® was tested for safety and efficacy in both animals and humans. Expand
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
TLDR
Oral TDF and TDF-FTC both protect against HIV-1 infection in heterosexual men and women, and both study medications significantly reduced the HIV- 1 incidence among both men andWomen. Expand
Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study.
TLDR
Among African women with a high prevalence of bacterial vaginosis and high adherence to PrEP, the efficacy of daily PrEP for HIV prevention did not differ significantly among women with abnormal versus healthy vaginal microbiota as defined by Nugent score, reassuring that oral PrEP delivery to women can continue without the need for concurrent testing for bacterialvaginosis or vaginal dysbiosis. Expand
Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa.
TLDR
Delivery of PrEP to HIV-negative partners within HIV serodiscordant couples was feasible and should be prioritized for wide-scale implementation, and incident HIV was rare in this PrEP demonstration project in East Africa. Expand
...
1
2
3
4
5
...